On Thursday, Shares of Cisco Systems, Inc. (NASDAQ:CSCO), subtract -0.56% and closed at $30.17 in the last trading session. The last trading range of the stock ranges between $29.86 and $30.25. FloSports recently declared new apps available on the Roku and Apple TV platforms that will give consumers direct access to its live events, documentaries, studio shows, highlights and other original video content across its network of sites. Using the Cisco Infinite Video Platform, FloSports now offers a complete multi-screen experience for the millions of sports fans it serves each month.
“As the leading direct-to-consumer sports media network, FloSports is committed to providing die-hard sports fans more content on more platforms across all devices,” FloSports co-founder and CEO Martin Floreani said. “Recently’s news gives the leagues, governing bodies and other rights holders we partner with the ability to showcase their events on the world’s most popular OTT platforms. We’re excited to give our subscribers the living room sports viewing experience that they want.”
The FloSports apps are free to download and include both free and premium content. Existing FloPRO subscribers on any FloSports website can view premium content with their existing login information, while new users can purchase FloPRO subscriptions via in-app purchases. Yearly subscribers to any FloSports website have universal access to premium content network-wide.
Abbott Laboratories (NYSE:ABT), remain flat and closed at $40.98 in the last trading session. The last trading range of the stock ranges between $40.41 and $41.24. The company’s Market capitalization is $59.98 Billion with the total Outstanding Shares of 1.47 Billion. Abbott Laboratories manufactures and sells health care products worldwide. The companys Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière’s disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; and influenza vaccines, in addition to to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and instrument used to identify infection-causing pathogens. The companys Nutritional Products segment provides pediatric and adult nutritional products, such as prepared infant and follow-on formulas. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, counting test strips, sensors, data administration decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices, and government agencies.
United Technologies Corporation (NYSE:UTX), jumped 0.93% and closed at $99.85 in the last trading session. The last trading range of the stock ranges between $98.15and $100.08. During the 52-week trading session the minimum price at which share price traded, registered at $83.39 and reached to max level of $109.83. United Technologies Corp.’s (UTX) Board of Directors recently declared a dividend of 66 cents per common share payable December 10 to shareowners of record at the close of business November 18.
UTC has paid cash dividends on its common stock every year since 1936.
United Technologies Corp., based in Farmington, Connecticut, provides high-technology systems and services to the building and aerospace industries. By combining a passion for science with precision engineering, the company is creating smart, sustainable solutions the world needs. For more information about the company, visit our website at www.utc.com or follow us on Twitter: @UTC.